Lp(a) enhances coronary atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits

Atherosclerosis

Volumn 193, Issue 2, 2007, Pages 269-276

  Kitajima, Shuji ^a   Jin, Yingji ^b   Koike, Tomonari ^b   Yu, Ying ^b   Liu, Enqi ^a   Shiomi, Masashi ^c   Marcovina, Santica M ^d   Morimoto, Masatoshi ^a   Watanabe, Teruo ^a,e   Fan, Jianglin ^b  

^a SAGA UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Kyurin Corporation   (Japan)

Author keywords

Coronary atherosclerosis; Hypercholesterolemia; Lp(a); Myocardial infarction; Transgenic rabbits; WHHL

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS BREEDING; EXTRACELLULAR MATRIX; HEART INFARCTION; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAINING; TRANSGENIC ANIMAL;

ANIMALS; CORONARY ARTERIOSCLEROSIS; HYPERLIPIDEMIAS; LIPOPROTEIN(A); MYOCARDIAL INFARCTION; ORGANISMS, GENETICALLY MODIFIED; RABBITS;

EID: 34447303327     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.08.056     Document Type: Article

References (35)

1. Berg K. A new serum type system in man: the Lp system. Acta Pathol Microbiol Scand 59 (1963) 369-382
2. Utermann G. The mysteries of lipoprotein(a). Science 246 (1989) 904-910
3. Kostner K.M., and Kostner G.M. Lipoprotein(a): a still enigma?. Curr Opin Lipidol 13 (2002) 391-396
4. Kostner G.M., Avogaro P., Cazzolato G., Marth E., Bittolo-Bon G., and Qunici G.B. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38 (1981) 51-61
5. Scanu A.M., Lawn R.M., and Berg K. Lipoprotein(a) and atherosclerosis. Ann Intern Med 115 (1991) 209-218
6. Maher V.M., and Brown B.G. Lipoprotein (a) and coronary heart disease. Curr Opin Lipid 6 (1995) 229-235
7. Koschinsky M.L. Lipoprotein(a) and atherosclerosis: new perspectives on the mechanism of action of an enigmatic lipoprotein. Curr Atheroscler Rep 7 (2005) 389-395
8. Boffa M.B., Marcovina S.M., and Koschinsky M.L. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. Clin Biochem 37 (2004) 333-343
9. Marcovina S.M., Koschinsky M.L., Albers J.J., and Skarlatos S. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions. Clin Chem 49 (2003) 1785-1796
10. Ridker P.M., Hennekens C.H., and Stampfer M.J. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 270 (1993) 2195-2199
11. Gurewich V., and Mittleman M. Lipoprotein(a) in coronary heart disease Is it a risk factor after all?. JAMA 271 (1994) 1025-1026
12. Beisiegel U. Lipoprotien(a) in the arterial wall. Curr Opin Lipidol 2 (1991) 317-323
13. Lawn R.M., Wade D.P., Hammer R.E., Chiesa G., Verstuyft J.G., and Rubin E.M. Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature 360 (1992) 670-672
14. Linton M.F., Farese Jr. R.V., Chiesa G., et al. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest 92 (1993) 3029-3037
15. Acquati F., Hammer R., Ercoli B., et al. Transgenic mice expressing a human apolipoprotein[a] allele. J Lipid Res 40 (1999) 994-1006
16. Schneider M., Witztum J.L., Young S.G., et al. Pitas RE: High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins. J Lipid Res 46 (2005) 769-778
17. Fan J., Shimoyamada H., Challah M., Honda K., and Watanabe T. Transgenic rabbits expressing human apolipoprotein (a) develop enhanced atherosclerotic lesions in response to a cholesterol-rich diet. Circulation 100 Suppl (1999) 1-698
18. Chiesa G., Hobbs H.H., Koschinsky M.L., Lawn R.M., Maika S.D., and Hammer R.E. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J Biol Chem 267 (1992) 24369-24374
19. Fan J., Shimoyamada H., Sun H., Marcovina S., Honda K., and Watanabe T. Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerotic lesions in response to a cholesterol-rich diet. Arterioscler Thromb Vasc Biol 21 (2001) 88-94
20. Ichikawa T., Unoki H., Sun H., et al. Lipoprotein (a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits. Am J Pathol 160 (2002) 227-236
21. Fan J., Challah M., Shimoyamada H., Shiomi M., Marcovina S., and Watanabe T. Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a]. J Lipid Res 41 (2000) 1004-1012
22. Watanabe Y., Ito T., and Shiomi M. The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits, an animal model for familial hypercholesterolemia. Atherosclerosis 56 (1985) 71-79
23. Armstrong V.W., Cremer P., Eberle E., et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 62 (1986) 249-257
24. Seed M., Hoppichler F., Reaveley D., et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. New Engl J Med 322 (1990) 1494-1499
25. Cantin B., Gagnon F., Moorjani S., et al. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. J Am Coll Cardiol 31 (1998) 519-525
26. Koike T., Liang J., Shiomi M., et al. Enhanced atherosclerosis in WHHL transgenic rabbits expressing lipoprotein lipase. Cardiovasc Res 65 (2005) 524-534
27. Fan J., Ji Z.-S., Huang Y., et al. Increased expression of apolioprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. J Clin Invest 101 (1998) 2151-2164
28. Sun H., Koike T., Ichikawa T., et al. C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol 167 (2005) 1139-1148
29. Podesser B., Wollenek G., Seitelberger R., et al. Epicardial branches of the coronary arteries and their distribution in the rabbit heart: the rabbit heart as a model of regional ischemia. Anat Rec 247 (1997) 521-527
30. Shiomi M., Ito T., Shiraishi M., and Watanabe Y. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis. Atherosclerosis 96 (1992) 43-52
31. Shiomi M., Ito T., Fujioka T., and Tsujita Y. Age-associated decrease in plasma cholesterol and changes in cholesterol metabolism in homozygous Watanabe heritable hyperlipidemic rabbits. Metabolism 49 (2000) 552-556
32. Shiomi M., Ito T., Yamada S., Kawashima S., and Fan J. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbits). Arterioscler Thromb Vasc Biol 23 (2003) 1239-1244
33. Shiomi M., Ito T., Hasegawa M., Yoshida K., and Gould K.L. Novel insights into coronary lumen preservation during progression of coronary atherosclerosis in coronary atherlsclerosis-prone rabbits. Coron Artery Dis 15 (2004) 419-426
34. Cullen P., Baetta R., Bellosta S., et al. Rupture of the atherosclerotic plaque: does a good animal model exist?. Arterioscler Thromb Vasc Biol 23 (2003) 535-542
35. Sharp R.J., Perugini M.A., Marcovina S.M., and McCormick S.P. A synthetic peptide that inhibits lipoprotein(a) assembly. Arterioscler Thromb Vasc Biol 23 (2003) 502-507